Literature DB >> 16040959

Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection.

Regina C Larocque1, Jason B Harris, Michelle Dziejman, Xiaoman Li, Ashraful I Khan, Abu S G Faruque, Shah M Faruque, G B Nair, Edward T Ryan, Firdausi Qadri, John J Mekalanos, Stephen B Calderwood.   

Abstract

Understanding gene expression by bacteria during the actual course of human infection may provide important insights into microbial pathogenesis. In this study, we evaluated the transcriptional profile of Vibrio cholerae, the causative agent of cholera, in clinical specimens from cholera patients. We collected samples of human stool and vomitus that were positive by dark-field microscopy for abundant vibrios and used a microarray to compare gene expression in organisms recovered directly from specimens collected during the early and late stages of human infection. Our results reveal that V. cholerae gene expression within the human host environment differs from patterns defined in in vitro models of pathogenesis. tcpA, the major subunit of the essential V. cholerae colonization factor, was significantly more highly expressed in early than in late stages of infection; however, the genes encoding cholera toxin were not highly expressed in either phase of human infection. Furthermore, expression of the virulence regulators toxRS and tcpPH was uncoupled. Interestingly, the pattern of gene expression indicates that the human upper intestine may be a uniquely suitable environment for the transfer of genetic elements that are important in the evolution of pathogenic strains of V. cholerae. These findings provide a more detailed assessment of the transcriptome of V. cholerae in the human host than previous studies of organisms in stool alone and have implications for cholera control and the design of improved vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040959      PMCID: PMC1201252          DOI: 10.1128/IAI.73.8.4488-4493.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Holliday junction processing in bacteria: insights from the evolutionary conservation of RuvABC, RecG, and RusA.

Authors:  G J Sharples; S M Ingleston; R G Lloyd
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

Authors:  Yee Hwa Yang; Sandrine Dudoit; Percy Luu; David M Lin; Vivian Peng; John Ngai; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

3.  Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis.

Authors:  Adel M Talaat; Susan T Howard; Walker Hale; Rick Lyons; Harold Garner; Stephen Albert Johnston
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

4.  Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease.

Authors:  Michelle Dziejman; Emmy Balon; Dana Boyd; Clare M Fraser; John F Heidelberg; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

5.  Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection.

Authors:  S H Lee; D L Hava; M K Waldor; A Camilli
Journal:  Cell       Date:  1999-12-10       Impact factor: 41.582

6.  ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients.

Authors:  James Bina; Jun Zhu; Michelle Dziejman; Shah Faruque; Stephen Calderwood; John Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 7.  Pathogenicity islands in bacterial pathogenesis.

Authors:  Herbert Schmidt; Michael Hensel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 8.  Pathogenicity islands and phages in Vibrio cholerae evolution.

Authors:  Shah M Faruque; John J Mekalanos
Journal:  Trends Microbiol       Date:  2003-11       Impact factor: 17.079

9.  DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae.

Authors:  J F Heidelberg; J A Eisen; W C Nelson; R A Clayton; M L Gwinn; R J Dodson; D H Haft; E K Hickey; J D Peterson; L Umayam; S R Gill; K E Nelson; T D Read; H Tettelin; D Richardson; M D Ermolaeva; J Vamathevan; S Bass; H Qin; I Dragoi; P Sellers; L McDonald; T Utterback; R D Fleishmann; W C Nierman; O White; S L Salzberg; H O Smith; R R Colwell; J J Mekalanos; J C Venter; C M Fraser
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

10.  Host-induced epidemic spread of the cholera bacterium.

Authors:  D Scott Merrell; Susan M Butler; Firdausi Qadri; Nadia A Dolganov; Ahsfaqul Alam; Mitchell B Cohen; Stephen B Calderwood; Gary K Schoolnik; Andrew Camilli
Journal:  Nature       Date:  2002-06-06       Impact factor: 49.962

View more
  57 in total

1.  Expression of putative virulence factors of Escherichia coli O157:H7 differs in bovine and human infections.

Authors:  Rebecca A Rashid; Tami A Tabata; Melissa J Oatley; Thomas E Besser; Phillip I Tarr; Steve L Moseley
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Vibrio cholerae OmpR Represses the ToxR Regulon in Response to Membrane Intercalating Agents That Are Prevalent in the Human Gastrointestinal Tract.

Authors:  D E Kunkle; T F Bina; X R Bina; J E Bina
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

3.  Transcriptional patterns in both host and bacterium underlie a daily rhythm of anatomical and metabolic change in a beneficial symbiosis.

Authors:  Andrew M Wier; Spencer V Nyholm; Mark J Mandel; R Prisca Massengo-Tiassé; Amy L Schaefer; Irina Koroleva; Sandra Splinter-Bondurant; Bartley Brown; Liliana Manzella; Einat Snir; Hakeem Almabrazi; Todd E Scheetz; Maria de Fatima Bonaldo; Thomas L Casavant; M Bento Soares; John E Cronan; Jennifer L Reed; Edward G Ruby; Margaret J McFall-Ngai
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

4.  Transcriptional profiling of Actinobacillus pleuropneumoniae during the acute phase of a natural infection in pigs.

Authors:  Vincent Deslandes; Martine Denicourt; Christiane Girard; Josée Harel; John H E Nash; Mario Jacques
Journal:  BMC Genomics       Date:  2010-02-08       Impact factor: 3.969

5.  Vibrio cholerae OmpR Contributes to Virulence Repression and Fitness at Alkaline pH.

Authors:  D E Kunkle; X R Bina; J E Bina
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

Review 6.  RNA profiling in host-pathogen interactions.

Authors:  Simon J Waddell; Philip D Butcher; Neil G Stoker
Journal:  Curr Opin Microbiol       Date:  2007-06-15       Impact factor: 7.934

7.  An in vivo expression technology screen for Vibrio cholerae genes expressed in human volunteers.

Authors:  Mary-Jane Lombardo; Jane Michalski; Hector Martinez-Wilson; Cara Morin; Tamara Hilton; Carlos G Osorio; James P Nataro; Carol O Tacket; Andrew Camilli; James B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

8.  Genomic and systems evolution in Vibrionaceae species.

Authors:  Jianying Gu; Jennifer Neary; Hong Cai; Audrey Moshfeghian; Stephen A Rodriguez; Timothy G Lilburn; Yufeng Wang
Journal:  BMC Genomics       Date:  2009-07-07       Impact factor: 3.969

9.  A bistable switch and anatomical site control Vibrio cholerae virulence gene expression in the intestine.

Authors:  Alex T Nielsen; Nadia A Dolganov; Thomas Rasmussen; Glen Otto; Michael C Miller; Stephen A Felt; Stéphanie Torreilles; Gary K Schoolnik
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

10.  Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium.

Authors:  Richelle C Charles; Jason B Harris; Michael R Chase; Lauren M Lebrun; Alaullah Sheikh; Regina C LaRocque; Tanya Logvinenko; Sean M Rollins; Abdullah Tarique; Elizabeth L Hohmann; Ian Rosenberg; Bryan Krastins; David A Sarracino; Firdausi Qadri; Stephen B Calderwood; Edward T Ryan
Journal:  PLoS One       Date:  2009-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.